xi's moments
Home | Macro

Entrepreneurs' proposals and suggestions for 2022 two sessions

chinadaily.com.cn | Updated: 2022-03-08 06:40

Zhao Chao, president of Buchang Pharma

Buchang Pharma president Zhao Chao. [Photo/Xinhua]

The operating revenue of China's pharmaceutical industry reached 2.35 trillion yuan ($371.98 billion) in the first 10 months of 2021, up 22.8 percent year-on-year, and the total profit of the industry increased 76.7 percent on a yearly basis.

Zhao Chao, president of Buchang Pharma and an NPC deputy, proposed more preferential policies to boost new medicine R&D, clinical trials and market introductions, as well as stimulate drug innovation and increase the accessibility of innovative drugs.

As traditional Chinese medicine has been extensively used in the treatment of COVID-19, Zhao also proposed TCM to be included in the national infectious disease prevention and control system.

|<< Previous 1 2 3 4 5 6 7 8 9 Next   >>|
Global Edition
BACK TO THE TOP
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349